Latest Share Chat

REMOVE ADS

Skinbiotherap. Share News (SBTX)

Skinbiotherap. Information

Share Price Information for Skinbiotherap. (SBTX)

Share Price is delayed by 15 minutes

Get Live Data

11.50 0.50 (4.55%)

Bid:

11.00

Ask:

12.00

Spread: 1.00 (9.091%)

Market Cap: £29.80m

Last checked at -

Intraday Skinbiotherap. Share Chart

REMOVE ADS

Skinbiotherap. News

SkinBioTherapeutics launches new consumer study into acne

(Sharecast News) - Life sciences company SkinBioTherapeutics said on Wednesday that it had begun a new consumer study into acne, with two new formulas...

IN BRIEF: SkinBio extends collaboration with Sederma for SkinBiotix

SkinBioTherapeutics PLC - Newcastle-based life science company focused on skin health - Extends its collaboration contract with Sederma SAS, the cosm...

AIM WINNERS & LOSERS: OnTheMarket surges on CoStar takeover

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

SkinBio gets approval to launch psoriasis treatment in France

(Alliance News) - SkinBioTherapeutics PLC on Friday said it has received approval from regulators to sell AxisBiotix-Ps, a food supplement designed to...

SkinBioTherapeutics gets France approval for psoriasis supplement

(Sharecast News) - SkinBioTherapeutics has been given the green light by French regulators to introduce its food supplement, AxisBiotix-Ps, into the F...

TRADING UPDATES: Literacy Capital nets profit on Butternut Box sale

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

SkinBioTherapeutics selects probiotic blends for acne study

(Sharecast News) - Skin health specialist SkinBioTherapeutics updated the market on its decision on the probiotic blends to be used in a consumer volu...

SkinBioTherapeutics launching psoriasis supplement in Italy

(Sharecast News) - Skin health specialist SkinBioTherapeutics has received regulatory approval to introduce 'AxisBiotix-Ps' - a food supplement design...